Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT)

Enrico Maffini, Myriam Labopin, Dietrich W. Beelen, Nicolaus Kröger, Mutlu Arat, Keith Wilson, Jacques‐Olivier Bay, Arnold Ganser, Hans Martin, Jakob Passweg, Panagiotis Kottaridis, Ibrahim Yakoub‐Agha, Rocío Parody Porras, Eva Wagner, Jordi Esteve, Francesco Lanza, Arnon Nagler, Mohamad Mohty